Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from InnoCare Pharma Ltd. ( (HK:9969) ).
InnoCare Pharma Ltd. has announced the composition of its board of directors and their roles in various committees. This update is significant as it reflects the company’s strategic leadership structure, which may influence its decision-making processes and governance, impacting stakeholders’ confidence in its corporate direction.
More about InnoCare Pharma Ltd.
InnoCare Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of drugs. The company is particularly active in creating therapies for cancer and autoimmune diseases.
YTD Price Performance: -7.84%
Average Trading Volume: 4,606,587
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$8.44B
For detailed information about 9969 stock, go to TipRanks’ Stock Analysis page.
